287 related articles for article (PubMed ID: 25817193)
1. Serum lipids, lipoproteins, and risk of breast cancer: a nested case-control study using multiple time points.
Martin LJ; Melnichouk O; Huszti E; Connelly PW; Greenberg CV; Minkin S; Boyd NF
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25817193
[TBL] [Abstract][Full Text] [Related]
2. Lipid biomarkers and long-term risk of cancer in the Women's Health Study.
Chandler PD; Song Y; Lin J; Zhang S; Sesso HD; Mora S; Giovannucci EL; Rexrode KE; Moorthy MV; Li C; Ridker PM; Lee IM; Manson JE; Buring JE; Wang L
Am J Clin Nutr; 2016 Jun; 103(6):1397-407. PubMed ID: 27099252
[TBL] [Abstract][Full Text] [Related]
3. The effect of preoperative serum triglycerides and high-density lipoprotein-cholesterol levels on the prognosis of breast cancer.
Li X; Tang H; Wang J; Xie X; Liu P; Kong Y; Ye F; Shuang Z; Xie Z; Xie X
Breast; 2017 Apr; 32():1-6. PubMed ID: 27939967
[TBL] [Abstract][Full Text] [Related]
4. [A case-control study on the association between serum lipid level and the risk of breast cancer].
Wei LJ; Zhang C; Zhang H; Wei X; Li SX; Liu JT; Ren XB
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1091-1095. PubMed ID: 28057114
[No Abstract] [Full Text] [Related]
5. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
[TBL] [Abstract][Full Text] [Related]
6. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer, heart disease, and whispering "fire" in a public theater.
Byers T; Goff D
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25817194
[No Abstract] [Full Text] [Related]
8. RE: Breast Cancer, Heart Disease, and Whispering "Fire" in a Public Theater.
Boyd N; Martin L
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26364304
[No Abstract] [Full Text] [Related]
9. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
10. Response.
Byers T; Goff D
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26364305
[No Abstract] [Full Text] [Related]
11. Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer.
Flote VG; Vettukattil R; Bathen TF; Egeland T; McTiernan A; Frydenberg H; Husøy A; Finstad SE; Lømo J; Garred Ø; Schlichting E; Wist EA; Thune I
Lipids Health Dis; 2016 Mar; 15():56. PubMed ID: 26970778
[TBL] [Abstract][Full Text] [Related]
12. Combined use of apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease.
Pan L; Lu G; Chen Z
Coron Artery Dis; 2014 Aug; 25(5):433-8. PubMed ID: 24608795
[TBL] [Abstract][Full Text] [Related]
13. Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk.
His M; Zelek L; Deschasaux M; Pouchieu C; Kesse-Guyot E; Hercberg S; Galan P; Latino-Martel P; Blacher J; Touvier M
Eur J Epidemiol; 2014 Feb; 29(2):119-32. PubMed ID: 24519551
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of leptin, insulin, and lipids in relation to breast cancer in china.
Han C; Zhang HT; Du L; Liu X; Jing J; Zhao X; Yang X; Tian B
Endocrine; 2005 Feb; 26(1):19-24. PubMed ID: 15805581
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients.
Liting P; Guoping L; Zhenyue C
Herz; 2015 Mar; 40 Suppl 1():1-7. PubMed ID: 25374385
[TBL] [Abstract][Full Text] [Related]
16. Uric acid blood levels and relationship with the components of metabolic syndrome in hypertensive patients.
Papavasileiou MV; Karamanou AG; Kalogeropoulos P; Moustakas G; Patsianis S; Pittaras A
J Hum Hypertens; 2016 Jul; 30(7):414-7. PubMed ID: 26134624
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial.
Vigna GB; Donegà P; Zanca R; Barban A; Passaro A; Pansini F; Bonaccorsi G; Mollica G; Fellin R
Metabolism; 2002 Nov; 51(11):1463-70. PubMed ID: 12404199
[TBL] [Abstract][Full Text] [Related]
19. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K
Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583
[TBL] [Abstract][Full Text] [Related]
20. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H
J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
